Conference Highlights

Cardiologist

Cardiologists are doctors who are specialized in cardiovascular system disease diagnosis and treatment.

It is necessary in the United States to complete four years of medical school, three years of internal medicine training, and at least three years of cardiology specialization.

Cardiac diseases that can be helped by a cardiologist, including: atherosclerosis, atrial fibrillation, arrhythmias, congenital heart disease, heart disease, congestive heart disease, high blood cholesterol and triglycerides, hypertension, pericarditis, ventricular tachycardia and hypertension.

A cardiologist will review the medical history of a patient and perform certain physical tests such as: electrocardiogram (ECG or EKG), ambulatory ECG, echocardiogram, cardiac catheterization, and nuclear cardiology.

Subtopics

Market Statistics:

The cardiology Surgical & Interventional Cardiology Devices Market was valued at $ 17.95 billion in 2019 and is expected to grow at a CAGR of 7.65% between 2020 and 2025.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Clinical Cardiology

Clinical cardiologists are trained physicians whose cardiac disease research include: congenital heart disease, coronary artery disease, valvular heart disease, heart failure and epidemiology, pathophysiology, aetiology, and genetics.

Special attention should be paid to studies involving the diagnosis, treatment and management of cardiac disorders such as: electrophysiology, cardiac medicine, cardiovascular implants, cardiac surgery, cardiac reconstruction and cardiovascular risk factors detection.

A professional cardiologist specializes in treating congenital heart disorders, endocarditis, pericarditis, high blood pressure and heart rhythms that are abnormal.

The pay is quite high for professional cardiologists, with a median salary of $316,000 for non-invasive surgeons.

Subtopics

Cardiovascular medicine | Preventive medicine | Sleep medicine | Percutaneous Coronary Intervention (PCI) | Modern practices in cardiovascular therapy

Market Statistics:

The global cardiovascular market is approximately $259.1 billion, of which $187 billion is for therapy and $72.1 billion is for devices. The cardiovascular market in the United States is approximately $81.35 billion, with therapy accounting for $50.49 billion and equipment accounting for $30.86 billion.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Heart Diseases

Cardiovascular disease or heart disease due to a variety of conditions, including coronary artery disease, heart rhythm (arrhythmias) and congenital heart defects.

There are two types of heart disease. Congenital disease of the heart 2. Cardiovascular disease acquired from heart disease describes the heart or blood vessel disease. Cardiovascular disease includes heart disease, stroke, heart failure, rheumatic heart disease, heart disease, cardiomyopathy, congenital heart disease, heart arrhythmia, heart disease, carditis, thromboembolic disease, aortic aneurysms, peripheral artery disease, and venous thrombosis.

Older adults are affected by most cardiovascular disease. In the United States, 11 percent of people aged 20 to 40 have CVD, while 37 percent of people aged 40 to 60 have CVDs, 71 percent of people aged 60 to 80 have CVDs, and 85 percent of people aged 80.

Subtopics

Market Statistics:

From $12.2 billion in 2014 to $22.5 billion in 2021, the market for technologies and goods used to treat coronary heart disease is expected to expand.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Hypertension

Hypertension is commonly referred to as hypertension (HBP). In which the arteries ' blood pressure is persistently elevated. A major risk factor for coronary artery disease, heart failure, stroke, atrial fibrillation, vision loss, peripheral vascular disease, chronic kidney disease, and dementia, is this long-term medical condition.

High blood pressure is graded as primary high blood pressure:· Approximately 90-95 percent of primary high blood pressure cases· Non-specific lifestyle, genetic factors, excess body weight, smoking, and alcohol are the main reasons for secondary high blood pressure:· Approximately 5-10 percent of secondary high blood pressure cases·

Hypertension can cause seizures, failure to thrive, irritability, reduced energy, and difficulty breathing in newborns and young infants. Hypertension can cause headache, unexplained irritability, failure to thrive, tiredness, nosebleeds, blurred vision, and facial paralysis in older infants and children.

Key hypertension prevention:· maintain normal adult body weight· minimize dietary sodium intake· require moderate physical activity· regulate alcohol consumption· raise the intake of fruit and vegetables

Subtopics

Market Statistics:

The hypertension market is the largest among the various heart disorders, accounting for $32 billion in prescription drug sales in 2018. The market is predicted to increase at a CAGR of 1.7% from 2018 to 2028.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Electrocardiography

Electrocardiography uses electrodes mounted on the skin over a period of time to monitor the heart's electrical activity. To identify any cardiac problems, this procedure is used.

ECG is used to obtain the heart's structure and function. Some indications for performing an ECG include: • Cardiac attack or chest pain • ST elevated myocardial infarction • Suspected pulmonary embolism • Cardiac whispering• Monitoring of known cardiac arrhythmias • Fainting• Seizures• Monitoring of cardiac effects• Hypertrophic cardiomyopathy • Cardiac stress testing • Computed tomography • Patient biotelemetry

Subtopics

Market Statistics:

Electrocardiograph The market was valued at $5.1 billion in 2020, and is expected to increase at a CAGR of 5.8% from 2021 to 2026. An electrocardiograph is a non-invasive test for checking and recording heart electrical activity.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardio-Oncology

Throughout cancer treatment, it is an interdisciplinary area of medicine that deals with clinical and molecular changes in the cardiovascular system, particularly chemotherapy and radiation therapy.

Patients with cardiac tumors usually experience infinite symptoms such as dyspnea, fatigue, thoracoabdominal pain, nausea, fever, hemoptysis, diarrhea, and weight loss.

The diagnosis is mostly based on clinical history; the patient has been diagnosed with cardiac tumors for the first time after a stroke, an embolism caused by weakened tumor tissue.

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Interventional Cardiology

Interventional cardiology is a cardiology sub-specialty that deals specifically with systemic heart disease treatment based on the catheter.

A large number of operations can be performed on the heart via catheterization.

Specific treatments for interventional cardiology include angioplasty, percutaneous coronary operation, valvuloplasty, congenital heart defect reversal, percutaneous valve replacement, percutaneous valve repair, and coronary thrombectomy. The main benefits of using cardiology or radiology intervention approaches are the avoidance of wounds, pain, and lengthy post-operative recovery.

Interventional cardiologists in the U.S. and Canada require a minimum of seven years of postgraduate medical education and those who wish to specialize in multiple structural cardiac procedures need up to nine years of postgraduate medical education.

Subtopics

Market Statistics:

Due to COVID-19, the worldwide interventional cardiology market size is expected to be roughly $11.1 billion in 2020, down from over $14 billion in 2019. The global market is predicted to reach an astounding $16.2 billion in 2027.

Boston Scientific, Abbott, and Medtronic collectively held more than 40% of the global interventional cardiology market share.

As a result of COVID19, the worldwide interventional cardiology market size declined by 20% from 2019 to 2020, reaching a valuation of $11.1 billion in 2020.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Nuclear Cardiology

Nuclear cardiology is a cardiology sub-specialty that conducts a wide variety of non-invasive cardiovascular imaging studies, including: myocardial perfusion imaging (nuclear stress testing) to diagnose and control coronary artery disease, radionuclide cineangiograms, and viability studies to determine the severity of myocardial infarction and to evaluate heart function.

Were studies in nuclear cardiology used to evaluate?

• Your heart function • Blood flow to the heart muscle • Lifestyle interventions and medicines • Best possible heart treatments• Whether shortness of breath, chest discomfort or fatigue is caused by heart disease.

A widest range of tests performed under Nuclear Cardiology are • Myocardial perfusion tests • Ventricular function studies • PET scans • Resting myocardial perfusion scan • MUGA scans

Subtopics

Market Statistics:

The nuclear medicine market is expected to grow at a 9.0 percent compound annual growth rate (CAGR) from USD 4.8 billion in 2021 to USD 7.5 billion in 2026.

This market is divided into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. In terms of the nuclear cardiology market, North America has remained ahead of the other regions due to its superior capacity to handle new and highly advanced technologies.

Furthermore, new low-cost technologies like PET and PACS imaging technology will drive up demand for nuclear cardiology devices.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiac Nursing

Cardiac nursing is a sub-specialty of nursing for patients suffering from different conditions and complications of the cardiovascular system. Heart nurses perform various tasks such as stress test tests, artery testing, heart monitoring, surgical unit postoperative treatment, and safety evaluations.

Cardiac nurses work in a variety of environments including coronary care units (CCU), intensive care units (ICU), cardiac catheterization, operating theatres, clinical research, cardiac rehabilitation centres, cardiovascular intensive care units, cardiac surgery wards and surgical wards.

Cardiac nurses are registered nurses who, under the supervision of a cardiologist, help treat numerous patient conditions such as unstable angina, coronary artery disease, cardiomyopathy, myocardial infarction, congestive heart failure and cardiac dysrhythmia.

Subtopics

Market Statistics:

Salary for cardiovascular nurses varies depending on experience, region, and education level. These individuals earn an average base income of $88,646 each year. Total pay for cardiovascular nursing salary ranges from $51,000 to $90,000.

In general, the job prognosis for nurses is also positive. According to the Bureau of Labor Statistics, the number of registered nurses will increase by 7% between 2019 and 2029. With the ageing of the Baby Boomer generation and the prevalence of heart disease in the United States, the need for cardiovascular nurse employment is expected to rise.

Overall, the Bureau of Labor Statistics predicts that the registered nurse profession will grow by 7% between 2019 and 2029, which is good news for nurses of all specialties. Cardiovascular health is likewise a high-demand component of the healthcare system. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, accounting for one out of every four deaths. In other words, there is still a demand for cardiovascular nursing employment in the sector.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Pediatric Cardiology

For rising and evolving people, pediatric cardiology is a sub-specialty in pediatrics concerned with heart disease.

Pediatric cardiologists are physicians who diagnose and treat children with heart disease, including • congenital heart disease• infant cardiovascular collapse • infant and child cardiac insufficiency • neonatal cyanosis • children with heart murmur • artery transposition • children and adolescents with chest pain• cardiovascular disorders• fetal heart murmur • artery transposition • children and adolescents with chest pain • cardiac defects•

• Management of critically ill children with heart problems Different procedures and procedures include: • Electrocardiogram (ECG) • Advanced imaging – CT / MRI • chest x-ray • exercise testing • pediatric cardiac transplantation • cardiac event recording • balloon atrial septostomy • cardiac ultrasound scans.

All pediatric cardiologists must complete specialized training in one of the following areas: • advanced imaging (CT / MRI) • advanced echocardiography • adult congenital heart disease • fetal cardiology • therapeutic catheterization • invasive electrophysiology • pulmonary hypotension • heart failure and cardiac transplantation

Subtopics

Market Statistics:

The worldwide paediatric interventional cardiology market is divided into two parts: device type and geography. The market is further divided into congenital heart defect closure devices, transcatheter heart valves, and others based on the kind of device (catheters, guidewires, balloons, and stents).

Interventional cardiology is a subspecialty of cardiology that treats coronary artery, valvular, and congenital heart disorders with intravascular catheter-based procedures and fluoroscopy. Pediatric interventional cardiology is the practise of performing interventional cardiology on newborns, children, and adolescents up to the age of 18.

St. Jude Medical (U.S.), Boston Scientific (U.S.), Gore Medical (U.S.), Abbott Vascular (U.S.), GE Healthcare (U.S.), Edward LifeSciences (U.S.) and Siemens Healthcare are among the market's major players (Germany).

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Stroke

A stroke is a medical condition that results in cell death due to decreased blood flow to the brain.

There are two main types of stroke: ischemic: due to lack of blood flow Hemorrhagic: due to bleeding Signs and symptoms of a stroke: it may cause dizziness, difficulties in understanding or communicating, loss of vision and inability to move or respond on one side of the body, pneumonia and loss of bladder control. Stroke symptoms can last for a long time.

Risk factors for Stroke include high blood pressure, high blood cholesterol, smoking tobacco, obesity, previous TIA, diabetes mellitus, blockage of a blood vessel, and atrial fibrillation.

Diagnosis and prevention: Diagnosis is usually based on a physical examination and is accompanied by medical imaging such as MRI or CT scanning, electrocardiogram (ECG) and blood testing to assess risk factors.

Prevention involves the elimination of risk factors, as well as the use of statins, aspirin, surgery to open up artery defect narrowing, and warfarin in those with atrial fibrillation.

Stroke is a leading cause of disability in the U.S. and has declined from the third to fourth leading cause of death recently. 95% of strokes occur in people over 45 years of age and 2/3 of strokes occur in people over 65 years of age.

Between 1990 and 2010, the number of strokes in the developing world increased by 10 percent and in the developed world dropped by 10 percent. Overall, 2/3 of the strokes registered in those over 65 years of age. South Asians are disproportionately high at risk of stroke, contributing 40% of deaths from strokes worldwide. Among women, 60% of stroke deaths occur, but men are 25% more likely than women to suffer from stroke.

Subtopics

Market Statistics:

The Global Stroke Management Market was worth $22,581 million in 2016 and is expected to be worth $36,756 million by 2023, expanding at a CAGR of 7.1 percent during the study period (2017-2023). Stroke is a medical emergency that occurs when blood flow to the brain is disrupted, causing brain cells to die.

The Stroke Management Market's Key Findings:
• The diagnostics sector dominated the market in 2016 and is expected to grow at the fastest CAGR of 8.1 percent in 2017.
• In 2016, the ischemic stroke category accounted for the largest share.
• In 2016, the United States was the largest shareholder in the North American stroke management market.
• During the analysis period, Asia-Pacific is predicted to have the highest growth rate.
• In the Asia-Pacific market, China is predicted to develop at the fastest CAGR.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiac Surgery

Cardiac surgeons are the doctors who conduct heart surgery or blood arteries to repair damage caused by cardiovascular system diseases. Complications such as ischemic heart disease, heart transplants, congenital heart disease, valvular heart disease including endocarditis, atherosclerosis, and rheumatic heart disease were treated.

Cardiac surgeons usually do:• Treat heart failure and heart disease • Repair or replace heart valves • Repair damaged or abnormal heart structures • Implant medical devices that support blood flow, heart beat and heart function • Control of abnormal heart rhythms.

Various types of heart surgery • Aortic surgery • Aortic ventricular surgery • Congenital heart surgery • Coronary artery bypass graft surgery • heart transplantation • Left ventricular surgery • Right ventricular surgery • Surgical ventricular repair • Myectomy / myotomy • Valvular surgery

Subtopics

Market Statistics:

The global market for cardiac surgical instruments is predicted to reach USD 1.63 billion by 2022, up from USD 1.16 billion in 2017, at a CAGR of 7.1%.

Europe dominated the global market in 2017, followed by North America. The European market is primarily driven by increased use of surgical treatments in cardiology, expansion in the European healthcare sector, and public awareness campaigns. The Asian market, on the other hand, is expected to grow at the fastest CAGR due to increased government and private sector spending in healthcare, rising purchasing power, and a high prevalence of cardiac disorders. China, India, and Japan are three of Asia's most important marketplaces.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Thrombosis

Thrombosis is the development of a blood clot within a blood vessel that prevents blood flow through the circulatory system. When a blood vessel is broken, the body releases platelets and fibrin to form a blood clot and prevent blood loss.

In veins or arteries, thrombosis can occur.

Venous thrombosis: leads to blockage of the affected part of the body Arterial thrombosis: it affects the blood supply and allows the artery to cause tissue damage.

Specific thrombosis forms depending on the affected vessel type 1. Venous thrombosis • Cerebral venous sinus thrombosis• Deep vein thrombosis• Budd-Chiari syndrome• Cerebral venous sinus thrombosis • Cavernous sinus thrombosis 2. Thrombosis of the heart• Stroke• Myocardial infarction 3. Limb ischemia Prevention: if there are no problems with bleeding, the use of heparin following surgery is standard preventive treatment.

Prevention: There are multiple thrombosis prevention approaches, including· Anticoagulation· Thrombolysis· Surgery· Endovascular therapy· Endovascular therapy

Subtopics

Acute Coronary Syndromes

Coronary arteries are the part of heart muscles, in which the blood flow decreases due to acute coronary syndromes results in failed to function properly. Most common symptoms associated with ACS are chest pain, nausea, sweating and diabetes mellitus in older patients.

ACS is most commonly connected with three clinical manifestations: These types are names as per the appearance of Electrocardiogram (ECG). 1. ST elevation myocardial infarction (STEMI, 30%), 2. Non ST elevation myocardial infarction (NSTEMI, 25%) 3. Unstable angina (38%)

Diagnosis:

Different diagnosis methods

• Electrocardiogram

• Imaging and blood tests

• Prediction scores

Prevention:

Acute coronary syndrome often reflects a degree of damage to the coronaries by atherosclerosis. Primary prevention of atherosclerosis is controlling the risk factors: healthy eating, exercise, treatment for hypertension and diabetes, avoiding smoking and controlling cholesterol levels; in patients with significant risk factors, aspirin has been shown to reduce the risk of cardiovascular events. Secondary prevention is discussed in myocardial infarction.

After a ban on smoking in all enclosed public places was introduced in Scotland in March 2006, there was a 17% reduction in hospital admissions for acute coronary syndrome. 67% of the decrease occurred in non-smokers.

Treatment:

People with presumed ACS are typically treated with aspirin, clopidogrel or ticagrelor, nitroglycerin, and if the chest discomfort persists morphine

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Heart Arrhythmia

Heart arrhythmia is a set of conditions where the heartbeat is irregular, too slow, or too fast. Bradycardia: A heart rate below 60 Tachycardia beats per minute: a heart rate in adult symptoms above 100 beats per minute: Arrhythmia typically has no symptoms. Yet some symptoms usually found in Arrhythmia patients, such as lightheadedness, palpitations, or feeling a pause between heartbeats, shortness of breath, passing out, or chest pain.

Four major types of arrhythmias exist:· Extra beats· Supraventricular tachycardia· Ventricular arrhythmias· Bradyarrhythmias

Diagnosis: The Electrocardiogram (ECG) and Holter monitor are different tests and procedures that can aid in the diagnosis of arrhythmia.

Treatment: It is possible to treat most arrhythmias effectively. Treatments may include medicines such as beta blockers, surgery, different medical procedures such as installing a pacemaker or procainamide agents to restore normal heart rhythm. Many forms of cases of arrhythmia lead to sudden death or heart arrest.

Arrhythmia is affecting millions. Around 80% of sudden cardiac death is the result of ventricular arrhythmias. Approximately 15% of all sudden cardiac deaths are caused by global cardiovascular disease.

Atrial fibrillation affects about 2% to 3% of the population in Europe and North America as of 2014.

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Valvular Heart Disease

Valvular heart failure is any disorder that affects one or more of the heart's four valves. Such disorders are caused by age, congenital (inborn) defects, pregnancy, and heart disease from rheumatism.

Treatment: Some of the most common treatments for valvular heart disease are briefly offered as: • Avoid excessive alcohol consumption • Do not smoke• Antibiotic drugs • Anti-Thrombotic drugs such as aspirin • Anticoagulant such as warfarin • Balloon dilatation • Medication for water pills

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Pulmonology and Cardiology

Cardiology is a branch of medicine that focuses on cardiovascular disease research, diagnosis and treatment. Cardiovascular diseases include heart disease, high blood pressure, arrhythmia, or stroke.

Pulmonology is a medical specialty dealing with diseases of the respiratory tract. Pulmonologists are trained in chest diseases, mainly pneumonia, asthma, emphysema, tuberculosis, and complicated infections of the chest.

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Atherosclerosis

Atherosclerosis is a condition that prevents the supply of oxygen-rich blood to parts of the body due to the accumulation of plaque.

Atherosclerosis is caused by abnormal levels of cholesterol, diabetes, obesity, high blood pressure, smoking, inherited, and unhealthy diet.

In the initial stage, no symptoms appear until serious, depending on which arteries are affected, it can lead to stroke, coronary artery disease, kidney problems and peripheral artery disease.

Atherosclerosis usually occurs in men in the 40s and women in the 50s to 60s.According to data from 2004, the first symptom of atherosclerotic cardiovascular disease results in heart attack or sudden cardiac death in about 66 percent of men and 47 percent of women in the United States.

Prevention: Usually by taking a healthy diet, not smoking, exercising, and keeping a normal weight.

Treatment: involves medicines for blood pressure, medicines for lowering cholesterol such as statins, or medications for reducing coagulation, such as aspirin. Also, various procedures such as coronary artery bypass grafting, percutaneous coronary intervention, or carotid endarterectomy can be performed.

Subtopics

Pathogenesis of Atherosclerosis | Chemokines and Atherosclerosis: A critical Assessment of Therapeutic Targets | Adhesion Molecules and Atherosclerosis | Cytokines and Atherosclerosis | Toll-Like Receptors in Atherosclerosis| PPAR-Based Therapies for the Management of Atherosclerosis | Pentraxins in Vascular Pathology | Metalloproteinase, the Endothelium and Atherosclerosis | Cathepsins in Atherosclerosis | The Plasmin system and Atherosclerosis | Mast Cell Proteases and Atherosclerosis | NADPH Oxidase and Atherosclerosis | Hene Oxygenase-1 and Atherosclerosis | Platelets: Role in Atherogenesis and thrombosis in Coronary Artery Disease

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Sports Cardiology

Sports cardiology is a cardiology sub-specialty where cardiologists, exercise physiologists, physicians, physical therapists, nurses, nutritionists, coaches, and psychologists are diagnosing and treating cardiac conditions in order to keep athletes healthy and competitive in sports.

To assess and treat symptoms, doctors work closely with individuals. We conduct• A thorough review of medical history• A thorough review of sporting history • Examine all heart problems and symptoms• Cardiovascular physical examination • Electrocardiogram • Laboratory testing • Cardiopulmonary exercise monitoring • Assessment and assessment in sports medicine • Physical therapy• Suggestion to remain active in sports • Training to improve efficiency in athletics

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiac Imaging

Cardiac imaging is a diagnostic radiology subspecialty in which cardiac radiologist conducts and then interprets medical images to diagnose heart disease, heart failure, heart failure, heart failure and heart shape, and leaky heart valves.

Cardiac (heart) imaging techniques include:· Coronary catheterization· Echocardiogram· Intravascular ultrasound· Cardiac PET scan· Cardiac CT scan· Cardiac MRI· X-rays These scans are used to diagnose cardiac signs, control the heart, assess and track heart failure and clinical congenital heart disease management.

Subtopics

Market Statistics:

The global market for Heart Imaging, which was valued at US$14.8 billion in 2020, is expected to reach a revised size of US$27.5 billion by 2027, rising at a CAGR of 9.3% between 2020 and 2027.

The market for structural heart imaging in the United States is expected to be worth $4 billion by 2020. China, the world's second largest economy, is expected to reach a projected market size of US$5.8 billion by 2027, with a CAGR of 12.3% from 2020 to 2027. Other notable geographic markets include Japan and Canada, which are expected to increase at 6.3% and 7.9%, respectively, between 2020 and 2027. Germany is expected to expand at a CAGR of about 7.2% in Europe.

Asia-Pacific is expected to reach US$3.9 billion by 2027, led by countries such as Australia, India, and South Korea, while Latin America will grow at a 9.4% CAGR during the analysis period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Vascular Biology

The vascular system consists of small and large vessels specifically designed to have different levels of blood flow and pressure depending on the body's location.

Vascular tissue consists of a different cell type population, including endothelial cells, pericytes, fibroblasts, smooth muscle cells, and other types of connective tissue cells. The amalgamation of these types of cells constitutes the vascular tissue and forms connections that allow active and passive transportation across the wall of the vessel.

Endothelial cells in the vascular tissue are also involved in a number of other tasks, including: supplying an inner layer to the heart and blood vessels · Discharge of bioactive molecules to affect local cell settings · Influence of normal microvascular growth and angiogenesis · Transfer of molecules from the blood to interstitial fluid · Contiguous smooth muscle relationship.

Subtopics

Market Statistics:

The global vascular grafts market was worth USD 1.6 billion in 2020, and it is predicted to increase at a CAGR of 6.8% between 2021 and 2028. The rising prevalence of cardiovascular illnesses, diabetes, and end-stage renal disease are all propelling the market. According to the American Heart Association, an estimated 121.5 million people in the United States suffer from cardiovascular disorders such as high blood pressure, chest pain, heart attack, and stroke.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiology Case Reports

A case report in medicine is a comprehensive report of an individual patient's signs, symptoms, diagnosis, treatment, management and follow-up. For science, medical and educational purposes, case reports can be circulated.

For medical-clinical research, evidence-based medicine, a case report plays a vital role and offers a case-based learning framework.

Case studies on cardiology are intended for: • Learning about medical cases or patients with heart problems offers valuable experience for cardiologists, physicians and paramedic personnel • Learning different diagnostic procedures from various medical cases• Positive and negative results, demographic profile of patients, tests and inquiries, including clinical photos, should be included in the case report.

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Geriatric Cardiology

Geriatric cardiology is a subdiscipline of cardiology and geriatric medicine dealing with cardiovascular disorders in the elderly.

In addition to vascular disorders such as atherosclerosis, peripheral arterial disease, cardiac disorders such as heart failure, myocardial infarction, arrhythmias, cardiomyopathy are the cause of morbidity and mortality in the elderly.

Subtopics

Market Statistics:

In 2015, the global geriatric medication market was worth roughly USD 540 billion. The fast growing geriatric population base is one of the primary elements contributing to its rapid expansion. The worldwide geriatric population was estimated to be approximately 809.4 million in 2012, according to UN estimations, and is expected to reach almost 1.13 billion by 2022, and exceed a value of over 2 billion by 2050.

The growing elderly population in the world, as well as the increasing incidence of cardiovascular illnesses, are two of the most important aspects driving market revenue growth.

A new report from Emergen Research estimates that the global interventional cardiology devices market had a value of USD 13.72 billion in 2020 and is predicted to grow to USD 26.84 billion in 2028, with a revenue compound annual growth rate of 8.7 percent over the forecast period of 2021-2028.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiovascular Pharmacology

Cardiovascular pharmacology focuses primarily on medications used in cardiovascular disease treatment, both existing and emerging groups of drugs.

Subtopics

The Cardiovascular Physiology and Pharmacology of Endothelin-I | Vascular Pharmacology of Epoxyeicosatrienoic Acids | Prostaglandins in Action | TP Receptors and Oxidative Stress | Regulation of Endothelial Cell Tetrahydrobiopterin | Polyphenol-Induced Endothelium-Dependent Relaxations | Organic Nitrates and Nitrate Tolerance | Vascular Actions of Adipokines | Cardiovascular Effects of Erythropoietin

Market Statistics:

By 2022, the global cardiovascular medicines market is expected to have grown from $141.1 billion in 2017 to $149.4 billion, representing a compound annual growth rate (CAGR) of 1.2 percent between 2017 and 2022.

Cardiovascular illnesses are one of the most common causes of death throughout the world. Following the American Heart Association's estimates, around 41.5 percent of the United States' population was suffering from some type of cardiovascular disease in 2015. This prevalence is expected to rise to 45 percent by 2035, according to the American Heart Association. Patients suffering from cardiovascular diseases are projected to increase in number as a result of a more sedentary lifestyle, shifting food habits, and an increase in risk factors.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Robotic Cardiac Surgery

Robotic surgery is often referred to as surgery with da Vinci. Robotic surgery is a heart surgery in which surgeons conduct heart surgery using small tools and robot-controlled devices.

Robotic surgery has several uses, including coronary artery bypass, valve surgery, heart defect repair, cardiac ablation, and tumor removal, in various heart-related procedures.

Robotic surgery benefits • Removal of tumors in the heart • Treatment of congenital heart conditions • Repair or replacement of leaky or rigid heart valves• Correct atrial fibrillation, a common type of arrhythmia • Minimally invasive treatment compared to open-heart surgery• Rapid healing.

• Less ricks compared to open-heart surgery• Less damage to the patient, including less discomfort • Shorter hospital stay (usually 3 to 4 days)• Diminished use of pain medications• Less bleeding • Diminished risk of infection Risks of robotic surgery The patient will undergo a series of pre-robotic surgery procedures during which the patient's age, medical history, gender, and environment should be treated.

Robotic cardiac surgery often entails risks, including:· Heart attack· Stroke· Infection· Death

Subtopics

Anesthesia for Robotic Cardiac Surgery | Robotic Mitral Valve Surgery | Robotic Coronary Bypass Graft on Beating Heart | Robotic Surgery in Congenital Heart Disease | Intraoperative Transesophageal Echocardiography | Hybrid coronary revascularization | Robotic Left Ventricular Epicardial Lead Implantation

Market Statistics:

The need for heart surgery is increasing over the world. During the period 2017-2025, robots will have a cumulative market value of $7.50 billion, owing to the large increase in the number of robot-based and computer-assisted cardiological surgery procedures for the treatment of heart problems.

According to industry estimates, the global surgical robots market is estimated to reach USD 6.4 billion in 2021 and to increase at a compound annual growth rate (CAGR) of 17.6 percent from 2021 to 2026. Surgical robots allow surgeons to perform complex surgical procedures with greater precision.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiac Regeneration

The use of stem cell and cell therapy to repair or replace damaged heart tissue is called cardiac regeneration.

There is hope that various tissues or portions of the heart will eventually develop and the ability to regenerate due to the progress in cardiac science and new scientific advances.

Subtopics

Market Statistics:

The global regenerative medicine market was estimated at USD 27.29 billion in 2020, and it is predicted to increase at a CAGR of 11.27% from 2021 to 2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Dyslipidemia

Dyslipidemia is an increase in blood lipids. The excessive increase in levels of insulin may also lead to dyslipidemia.

Subtopics

Market Statistics:

The global dyslipidemia drug market was worth US$ 11.8 billion in 2018 and is expected to grow at a CAGR of 3.5% from 2019 to 2027.

North America is the leading contributor to the dyslipidemia medications market. According to the Centers for Disease Control and Prevention (CDC), over 95 million adults in the United States (55% of the population) had total cholesterol levels greater than 200 mg/dL as of 2016. Furthermore, total cholesterol levels higher than 240 mg/dL affect an estimated 29 million adults in the United States.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cardiovascular disease

Cardiovascular disease (CVD) can be a general term for heart or blood vessel conditions.
It is sometimes associated with an accumulation of fatty deposits in the arteries (atherosclerosis) and an exaggerated risk of blood clots.
It may even be associated with artery injury in organs such as the brain, heart, kidneys, and eyes.
Cardiovascular disease is one of the most common causes of death and disability in the UK of Great Britain and Northern Ireland, but it will usually be prevented by leading a healthy lifestyle.

Subtopics:

Market Statistics:

The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombotic events, is expected to expand from $129.2 billion in 2015 to $146.4 billion by 2022.

The global cardiovascular devices market is expected to grow at a 6.9% CAGR from USD 54.08 billion in 2021 to USD 86.27 billion in 2028.

The global cardiovascular medicines market is predicted to increase at a CAGR of 5.3% from $87.79 billion in 2020 to $92.41 billion in 2021. The increase is primarily due to companies reorganising their operations and recovering from the impact of COVID-19. At a CAGR of 4%, the market is estimated to reach $107.77 billion in 2025.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Congestive Heart Failure

We depend on the heart's pumping action to provide blood that is rich in nutrients and oxygen to each cell within the body. When cells are not well nourished, the body can not function properly.
The patient is exhausted and breathless if the heart is weakened and can not give enough blood to the cells. It becomes impossible to do everyday activities that were once taken as a privilege.
Heart failure can be a severe condition, and usually there is no remedy. However, the patient will still lead a pleasant, meaningful and productive life with proper treatment.

Subtopics

Epidemiology & pathophysiology of heart failure | Differential Diagnosis of Congestive heart failure | Pharmacologic theraphy of Heart Failure | Clinical approach to acute heart failure | Clinical approach to chronic heart failure | The diagnosis and management of Congestive heart failure

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Acute Coronary Syndrome

Coronary arteries are the portion of the heart muscles in which the blood flow reduces as a result of acute coronary syndromes that fail to function properly. For older patients, chest pain, nausea, vomiting, and diabetes mellitus are the most common symptoms associated with ACS.

ACS is most commonly associated with three clinical manifestations: names according to the Electrocardiogram (ECG) appearance. 1. Myocardial infarction with ST elevation (STEMI, 30 percent), 2. Non-ST myocardial infarction elevation (NSTEMI, 25%) 3. Diagnosis: Different methods of diagnosis • Electrocardiogram • Imaging and blood testing • Scores of prediction

Prevention: Acute coronary syndrome often reflects some degree of atherosclerosis damage to the coronaries. Primary atherosclerosis prevention controls the risk factors: healthy eating, exercise, hypertension and diabetes treatment, avoiding smoking and cholesterol levels; aspirin has been shown to reduce the risk of cardiovascular events in patients with significant risk factors. In myocardial infarction, secondary prevention is discussed.

Following the introduction of a smoking ban in all enclosed public places in Scotland in March 2006, hospital admissions for acute coronary syndrome were reduced by 17 percent. 67% of the decrease occurred in non-smokers.

Treatment: People with presumed ACS are typically treated with nitroglycerin, aspirin, clopidogrel or ticagrelor, and if morphine persists in the chest.

Subtopics

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Scope & Importance

The field of cardiology is one that is undergoing tremendous change at the moment. People living in this era, regardless of age, are at risk for developing cardiovascular diseases, the primary causes of which are the lifestyles they lead and the lack of proper hygiene they practise. Cardiology has become more important over time as a way to fight these diseases and the things that cause them. Interventional cardiology is a subspecialty of cardiology that treats disorders through the use of catheter-based minimally invasive treatments. This enables both patients and their treating physicians to complete the surgery with less blood loss and minor complications.

Some scientific advances in the fields of sciences, interventional cardiology, and cryopreservation are also predicted to drive the cardiac surgery devices market. The use of expanded Polytetrafluoroethylene for cardiovascular patches, the introduction of transcatheter heart valves, and thus the process of minimally invasive technologies, such as transcatheter semi-lunar valve implantation or transcatheter aortic valve replacement, are just a few of the factors that are expected to drive growth over the forecast period. Furthermore, changes in cryopreservation technologies by key players like CryoLife are among major technological breakthroughs in cardiac surgery therapies that are expected to positively influence the market.

The presence of technologically advanced cardiology and cardiovascular valves, grafts, and patches, as well as an increase in the generality of congenital heart defects, are among the basic variables projected to drive development over the forecast period. During the projection period of 2017-2023, the global market for heart transplants is expected to develop at a CAGR (Compound Annual Growth Rate) of 11.2 percent. The global Interventional Cardiology market is expected to develop slowly at a CAGR of almost 7% during the forecast period. The increased need for minimally invasive (MI) procedures will boost the global interventional cardiology market's growth prospects in the future years.The global interventional cardiology devices market is expected to be worth USD 21.2 billion by 2025, up from USD 13.8 billion in 2020, at an 8.9 percent CAGR during the forecast period. The significant rise in the geriatric population, prevalence of coronary artery diseases, the approval of new and sophisticated products, and thus the rising incidence of diabetes, are all driving growth in this industry.

Cardiology Market in Asia-Pacific:

It is anticipated that the Asia Pacific Interventional Cardiology Market will reach USD 41,00.3 Million by the end of the estimated period (2020-2027), expanding at a compound annual growth rate (CAGR) of 8%.

According to the International Diabetes Federation, Asia is home to 60% of the world's diabetes population. Diabetes is one of the leading causes of cardiovascular disease. The rising prevalence of cardiovascular illnesses is the primary driver of market growth in Asia Pacific. Aside from the rising prevalence of diabetes and obesity, changes in lifestyle, more public awareness, and quick technological advancements all contributed to the market's expansion. On the other hand, high cost for manufacturing the devices and a lot of barriers for the course of the new device are the main restraints hampering the market growth.

Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, and Terumo Corporation are some of the firms that are aiding in the expansion of the market for cardiovascular devices in the Asia-Pacific region.

Cardiology Market in Europe:

The Europe region market for Cardiology management devices, Aortic Repair devices, transcatheter embolization and occlusion devices will grow through 2026, driven by factors such as an ageing population, sedentary lifestyle and changes in food habits, advancements in the field of cardiology as well as an increase in the number of interventional cardiologists, and increasing demand for surgical occlusion devices.

The European Interventional Cardiology Market shrank by roughly 27% from 2019 as a result of COVID19, with a valuation of about €928 million in 2020. In 2022, the market size is anticipated to surpass pre-COVID19 levels, and in 2026, it will reach €1 billion.

In the year 2022, the total market size for cardiovascular devices in the European region was estimated to be worth USD 14.47 billion. It is further anticipated that this value would increase at a compound annual growth rate of 6.42 percent from 2022 to 2027, reaching a value of USD 19.75 billion by 2027.In the year 2022, the total market size for cardiovascular devices in the European region was estimated to be worth USD 14.47 billion. It is further anticipated that this value would increase at a CAGR of 6.42% from 2022 to 2027, reaching a value of USD 19.75 billion by 2027.

Cardiology Market in America:

Geographically, North America has the highest market share in 2019 due to increased awareness of gut illnesses. According to the Centers for Disease Control and Prevention (CDC), approximately 610,000 Americans die of heart disease each year. Similarly, 735,000 Americans die of heart attacks each year. Thus, an increase in heart attacks in North America would increase the demand for cardiovascular drugs. However, Asia-Pacific region is predicted to showcase the fastest rate of growth within the future due to the rise in the aging population, increasing awareness and other factors.

The global market for cardiovascular devices is projected to increase from $48.10 billion in 2021 to $76.52 billion in 2028, representing a CAGR of 6.9% for the forecast period of 2021-2028.

Cardiology Market in Middle East:

Countries in the Middle East and Africa bear an important burden from Ischemic heart conditions. Consistent with Dubai Health Authority, heart condition is the cause for each 3 in 10 deaths within the UAE. Huge funding in R&D and various initiatives by the government is driving the expansion of the Ischemic heart condition market in the Middle East and Africa. The Middle-East and Africa Ischemic heart condition market is growing steadily. The market is growing at the CAGR of three .1% and expected to succeed in to US$ 2.84 billion by 2022.

In the forecasted period of 2022 to 2029, the Middle East interventional cardiology and peripheral vascular devices market is anticipated to develop. According to Data Bridge Market Research's analysis, the market is expanding with a CAGR of 5.3% from 2022 to 2029 and is anticipated to rise from USD 400.11 million in 2021 to USD 579.59 million by that time. Increased prevalence of ischemic heart disease, vascular disease, and coronary artery disease, as well as a rise in public awareness of the need for prompt diagnosis and usage of devices, are projected to be the main factors driving market demand throughout the forecast period.

Cardiology Market in China:

In 2018, the market for cardiovascular devices in China was worth USD 2,837.51 million. By 2024, it is expected to be worth USD 4,468.02 million, with a CAGR of 7.86 percent over the next five years.

Future Cardiology reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage also will reflect the main technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and knowledge management issues.

Cardiology Journals | Cardiology Open Access

Heart Disease Organizations Worldwide | Cardiology Associtations

Abiomed / Alliance for Heart Failure / American Academy of Cardiovascular Perfusion / American College of Cardiology / American Heart Association / American Society of Nuclear Cardiology / Association for Inherited Cardiac Conditions / Atrial Fibrillation Association / Baker Heart and Diabetes Institute / Blood Pressure Association / British Cardiovascular Society / British Heart Foundation / Canadian Cardiovascular Society / Cardiac Risk in the Young / Cardiovascular Cell Therapy Research Network / Cardiovascular System Dynamics Society / Children's Cardiomyopathy Foundation / Congenital Heart Surgeons' Society / Corindus Vascular Robotics / Deutsche Gesellschaft für Kardiologie / European Association for Cardio-Thoracic Surgery / European Society of Cardiology / GISSI / Heart and Diabetes Center North Rhine-Westphalia / Heart and Stroke Foundation of Canada / Heart Failure Society of America / Heart Institute, University of São Paulo / Heart Research Institute / Heart Research UK / Heart Rhythm Society / Heart Support of America / Indian Heart Association / Institute of Cardiovascular & Medical Sciences / Interamerican Society of Cardiology / International Society for Heart Research / Krishna Heart Institute / Libin Cardiovascular Institute of Alberta / Lourdes Heart Institute / Mended Hearts / Montreal Heart Institute / Montreal Heart Institute Foundation / Mount Sinai Medical Center (Miami) / Multan Institute of Cardiology / National Heart Forum / National Heart Foundation (Bangladesh) / National Heart Foundation of Australia / National Heart Foundation of New Zealand / National Heart Institute (Malaysia) / Philippine Heart Center / Pulmonary Hypertension Association / Punjab Institute of Cardiology / Rabindranath Tagore International Institute of Cardiac Sciences / Resuscitation Council UK / Society for Cardiovascular Magnetic Resonance / Sri Jayadeva Institute of Cardiovascular Sciences and Research / Surgeons of Hope / Tanzania Heart Institute / The Texas Heart Institute / Tiny Tickers / Uganda Heart Institute / United OneHeart Foundation / University of Ottawa Heart Institute / Victor Chang Cardiac Research Institute / West of Scotland Heart and Lung Centre

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Conference

Our Experts

General Info

get in touch

quick links

2nd International Congress on Advanced Cardiology and Cardiovascular Research

Why Should You Attend Adv Cardiology2023?

PRESENTATION

CONNECT

EXCEL

PUBLICATION

COLLABORATION AND FRIENDSHIP

REINVENT SKILLS IN PROFESSIONAL DEVELOPMENT WORKSHOPS

LEARN ABOUT THE LATEST DEVELOPMENTS

CAPITALIZE ON YOUR TIME BY VISITING THE EXHIBITS

GET EXCEPTIONAL VALUE FOR YOUR REGISTRATION FEE

TRAVELING

Event summary

Adv Cardiology2023 conference

Welcome Message

SPEAKER LINE-UP

Harvey S Borovetz

Dhanjoo N Ghista

Roberto Sanchez

Jose E Herrera

Scientific Sessions

Conference Highlights

Cardiologist

15 seats

20 mins

Clinical Cardiology

15 seats

20 mins

Heart Diseases

15 seats

20 mins

Hypertension

15 seats

20 mins

Electrocardiography

15 seats

20 mins

Cardio-Oncology

15 seats

20 mins

Interventional Cardiology

15 seats

20 mins

Nuclear Cardiology

15 seats

20 mins

Cardiac Nursing

15 seats

20 mins

Pediatric Cardiology

15 seats

20 mins

Stroke

15 seats

20 mins

Cardiac Surgery

15 seats

20 mins

Thrombosis

15 seats

20 mins

Heart Arrhythmia

15 seats

20 mins

Valvular Heart Disease

15 seats

20 mins

Pulmonology and Cardiology

15 seats

20 mins

Atherosclerosis

15 seats

20 mins

Sports Cardiology

15 seats